Sign In
Buy BAYRY
$9.92
+0.0400 (+0.405%)
At Close: Jun 03, 2026
Hunting For Recession-Proof Bargains: 10 Picks As Prey
08:35am, Monday, 29'th Mar 2021
In the following article, I present 10 recession-proof stocks that are undervalued right now. Including companies from the healthcare sector like Gilead Sciences, Amgen, Novo Nordisk, Walgreens Boots
Bayer: Enough With The Bad News
09:40am, Friday, 19'th Mar 2021
Bayer reported solid results for fiscal 2020 with revenue and core EPS being more or less stable compared to fiscal 2019. A few weeks ago, Bayer also settled the glyphosate litigations.
After Acquiring Bayer Animal Health, Elanco Is Poised for Earnings Growth in 2021
07:45am, Tuesday, 16'th Mar 2021
Elanco just completed its largest merger ever. Now it turns its attention to ambitious earnings growth goals in 2021.
Bayer predicts mid-term earnings growth on agriculture, consumer health
07:30am, Wednesday, 10'th Mar 2021
Germany's Bayer on Wednesday pledged to boost adjusted earnings growth until 2024, helped by the launch of digital farming services, soy seeds and consumer health products.
TransCode Therapeutics Starts $29 Million IPO Effort
04:55pm, Sunday, 07'th Mar 2021
TransCode Therapeutics Starts $29 Million IPO Effort
Charles de Vaulx's Top 4th-Quarter Trades
05:43pm, Tuesday, 02'nd Mar 2021
Charles de Vaulx ( Trades , Portfolio ), chief investment officer of International Value Advisors, has revealed the IVA Worldwide Fund portfolio for the fourth quarter of 2020. Top trades include new
Bayer AG (BAYZF) CEO Werner Baumann on Q4 2020 Results - Earnings Call Transcript
11:55pm, Thursday, 25'th Feb 2021
Bayer AG (BAYZF) CEO Werner Baumann on Q4 2020 Results - Earnings Call Transcript
Bayer's (BAYRY) Q4 Earnings Match Estimates, Sales Miss
11:24am, Thursday, 25'th Feb 2021
Bayer (BAYRY) reports in-line earnings and misses sales estimates in the fourth quarter of 2020.
Predictive Oncology: Potentially Undervalued Drug Discovery AI Company
03:11pm, Wednesday, 24'th Feb 2021
Predictive Oncology: Potentially Undervalued Drug Discovery AI Company
February 2021 Undervaluation - Financials, Real Estate, Industrials/IT And Pharma
12:30pm, Thursday, 11'th Feb 2021
February 2021 Undervaluation - Financials, Real Estate, Industrials/IT And Pharma
Bayer reaches $2 billion deal over future Roundup cancer claims
01:42pm, Wednesday, 03'rd Feb 2021
Bayer AG struck a $2 billion deal to resolve future legal claims that its widely used weedkiller Roundup causes cancer, the German company said on Wednesday.
Bayer announces agreement with plaintiffs' counsel on class plan
12:00pm, Wednesday, 03'rd Feb 2021
LEVERKUSEN, Germany--(BUSINESS WIRE)--Bayer announced today a formal agreement with plaintiffs' class counsel on a class plan designed to manage and resolve future Roundup™ cases. Plaintiffs' class
READING, England--(BUSINESS WIRE)--Bayer has received approval for the use of its oral Factor Xa inhibitor Xarelto®▼ (rivaroxaban) to treat VTE and to prevent VTE recurrence in children from birth
Bayer (BAYRY) Gets a Boost With Product Approvals and Deals
09:47am, Tuesday, 26'th Jan 2021
Bayer (BAYRY) gets a boost as it wins approvals for a few candidates and enters into collaboration agreements.
Investors sue Bayer over stock's slump in wake of Roundup litigation
07:39am, Friday, 22'nd Jan 2021
Two law firms are suing Bayer for damages on behalf of shareholders, claiming the German group's management should have warned of the risk of lawsuits over the Roundup weedkiller when Bayer acquired R
